Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Saredutant in Major Depressive Disorder
NCT00250614Phase 3Completed
- Sponsor
- Sanofi
- Start
- Apr 2005
- Primary completion
- Oct 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of saredutant in major depressive disorder (MDD), sponsored by Sanofi. Started Apr 2005; status: completed.
02
Drugs
saredutant
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00250614.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00250614.